Home > Specialists > Gastrointestinal Surgery > Dr. Mingzhe Ma (马明哲)
Specialty & Clinical Focus:
Gastrointestinal surgery specialist at Fudan University Shanghai Cancer Center in Shanghai, with a clinical focus on open and minimally invasive surgery for gastric tumors, function-preserving gastrectomy, anti-reflux reconstruction, ERAS, and neoadjuvant, adjuvant, and conversion therapy for advanced gastric cancer.
Professional Title & Qualifications:
Associate Chief Physician
MD
PhD
Hospital & Department：
Fudan University Shanghai Cancer Center – Department of Gastric Surgery
(address: No. 270 Dong'an Road, Xuhui District, Shanghai, 200032)
Dr. Mingzhe Ma (马明哲) - Gastric Surgery Specialist
Personal Biography
Dr. Mingzhe Ma is an Associate Chief Physician in the Department of Gastric Surgery at Fudan University Shanghai Cancer Center, with a clinical focus on gastric tumors and gastric cancer surgery. His clinical work includes laparoscopic radical gastrectomy, function-preserving surgery, and neoadjuvant, adjuvant, and conversion therapy for advanced gastric cancer. He holds a Ph.D. from Shanghai Jiao Tong University and has completed academic training or visiting scholar programs at Harvard Medical School, Dana-Farber Cancer Institute, Jichi Medical University, and Linköping University. Dr. Ma is a member of the International Gastric Cancer Association (IGCA) and the China Anti-Cancer Association (CACA), and has participated in the Shanghai Medical Star and Harvard Global Clinical Scholars Research Training programs.
Why Consider Dr. Mingzhe Ma for Your Care?
Dr. Mingzhe Ma is an Associate Chief Physician in the Department of Gastric Surgery at Fudan University Shanghai Cancer Center. His clinical work centers on gastric tumors and includes laparoscopic and open surgery, pylorus- and nerve-preserving gastrectomy, anti-reflux reconstruction, and Enhanced Recovery After Surgery (ERAS). His academic background includes a Ph.D. from Shanghai Jiao Tong University and training or visiting scholar experience at Harvard Medical School, Dana-Farber Cancer Institute, Jichi Medical University, and Linköping University.
For patients with early or advanced gastric cancer, Dr. Ma's stated clinical scope also includes minimally invasive treatment, neoadjuvant and adjuvant therapy, and conversion therapy. His profile may therefore be particularly relevant to patients comparing surgical approaches, function-preserving options, or treatment pathways before deciding whether to pursue specialist care in Shanghai.
A remote specialist review before travel can help organize the key pathology, imaging, previous treatment history, and patient questions for Dr. Ma's review, giving international patients a clearer basis for discussing possible next steps and planning any subsequent hospital visit.
Pre-Travel Case Review & Specialist Liaison
International travel for gastric cancer care is easier to plan when the specialist review takes place before flights and hospital arrangements are finalized. MedBridgeNZ can coordinate a remote specialist-review pathway with Dr. Mingzhe Ma, including medical-record preparation, translation coordination, client-authorized document transfer, and appointment communication with the relevant hospital team.
Once the remote specialist review is arranged, Dr. Ma reviews the submitted records, provides his specialist opinion and recommendations, and responds to the patient's questions. This pre-travel review can help clarify potential treatment pathways and identify any additional records or in-person evaluation that may be needed before the patient decides whether to proceed with medical travel to Shanghai.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Mingzhe Ma
Areas of Expertise
Open and minimally invasive surgery for gastric tumors (including gastric cancer, antral cancer, corpus cancer, cardiac cancer, and gastrointestinal stromal tumors).
Pylorus-preserving and nerve-preserving gastrectomy.
Anti-reflux anastomosis for cardiac cancer (e.g., double-tract reconstruction).
Enhanced Recovery After Surgery (ERAS) for gastric cancer.
Minimally invasive treatment for early-stage gastric cancer.
Neoadjuvant and adjuvant therapy for advanced gastric cancer.
Conversion therapy for late-stage gastric cancer.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
3,400 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
Aug 2020 – Present: Associate Chief Physician, Fudan University Shanghai Cancer Center
Aug 2017 – Jul 2020: Attending Physician, Fudan University Shanghai Cancer Center
Aug 2015 – Jul 2017: Resident Physician, Fudan University Shanghai Cancer Center
Education & Training
Education
Ph.D. in Surgery: Shanghai Jiao Tong University
Master's in Clinical Medicine (7-year program): Shanghai Jiao Tong University
Bachelor's in Clinical Medicine (7-year program): Shanghai Jiao Tong University
Visiting Scholar Experience
Dec 2019 – Oct 2020: Global Clinical Scholars Research Training (GCSRT), Harvard Medical School, USA
Dec 2017 – Jan 2018: Jichi Medical University, Japan (Focus: Comprehensive treatment of gastric cancer with peritoneal metastasis)
Dec 2013 – May 2014: Dana-Farber Cancer Institute, Harvard Medical School, USA
Jun 2009 – Dec 2009: Linköping University, Sweden
Awards & Honors
2021: Second Prize, Anhui Province Science and Technology Award (Ranked 3rd)
2020: Outstanding Trainee Award, Shanghai Young Physician Training Plan
Academic & Professional Memberships
Member, International Gastric Cancer Association (IGCA)
Member, China Anti-Cancer Association (CACA)
Member, Abdominal Surgery Committee, China Medicine Education Association
Member, Gastrointestinal Tumor Committee, Shanghai Anti-Cancer Association
Senior Editorial Board Member, World Journal of Gastrointestinal Surgery
Senior Editorial Board Member, World Journal of Gastroenterology
Senior Editorial Board Member, Frontiers in Oncology
Invited Reviewer, Molecular Therapy
Research & Publications
Published over 20 SCI papers in authoritative international journals such as Cancer Research, focusing on the clinical and biological behavioral characteristics of gastric cancer.
Presided over one National Natural Science Foundation of China (NSFC) Youth Project and one General Project.
Presided over one Shanghai Natural Science Foundation project.
Participated in the Shanghai Young Physician Training Plan.
Presented research findings on conversion therapy for advanced gastric cancer at major domestic and international conferences, including KINGCA (Korea International Gastric Cancer Week) and IGCC (International Gastric Cancer Congress).
Selected Peer-Reviewed Publications
Selected peer-reviewed research by Dr. Ma related to gastric cancer:
Ma M, Lu S, et al. Identification and external validation of a novel miRNA signature for lymph node metastasis prediction in submucosal-invasive gastric cancer patients. Cancer Medicine. 2019;8(14):6315–6325. PMID: 31486298
Ma M, Weng M, et al. Systemic inflammation score is a prognostic marker after curative resection in gastric cancer. ANZ Journal of Surgery. 2019;89(4):377–382. PMID: 30854753
Yang H, Li Q, et al. Targeting SOX13 inhibits assembly of respiratory chain supercomplexes to overcome ferroptosis resistance in gastric cancer. Nature Communications. 2024;15(1):4296. PMID: 38769295
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Is Dr. Ma's surgical expertise relevant to my specific gastric cancer case?
Dr. Ma's stated clinical scope includes open and minimally invasive surgery for gastric tumors, pylorus- and nerve-preserving gastrectomy, anti-reflux reconstruction, ERAS, minimally invasive treatment for early-stage gastric cancer, and neoadjuvant, adjuvant, and conversion therapy for advanced disease. A remote specialist review can help clarify how these approaches relate to your individual case. Once the review is arranged, Dr. Ma reviews your submitted records, provides his specialist opinion and recommendations, and answers the questions you have prepared before travel.
How can I request a remote specialist review with Dr. Ma from outside China?
MedBridgeNZ coordinates the administrative pathway for international patients, including medical-record preparation, translation coordination, client-authorized transfer to the hospital team, and appointment communication. Once the specialist review is arranged, Dr. Ma reviews the submitted materials and responds with his opinion, recommendations, and answers to your questions. If you later want an onsite visit at Fudan University Shanghai Cancer Center, MedBridgeNZ can also coordinate the hospital appointment request and related documentation, subject to hospital scheduling.
What support is available if I decide to travel to Shanghai for treatment?
After the remote review, MedBridgeNZ can coordinate the non-clinical logistics for a medical trip to Shanghai. Support can include hospital appointment communication, medical invitation or visa-document coordination, travel and accommodation planning, medical-record translation coordination, and non-clinical bilingual administrative support during hospital visits where arranged. This helps reduce language and administrative friction while Dr. Ma and the hospital clinical team focus on medical evaluation and treatment decisions.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking specialist care in China. For patients considering Dr. Mingzhe Ma in Shanghai, we coordinate appointment requests, medical-record preparation, translation, client-authorized document transfer, medical invitation or visa-document support, travel planning, and non-clinical bilingual administrative support. MedBridgeNZ does not provide medical advice, diagnosis, or treatment. Third-party medical and travel costs remain separate from MedBridgeNZ coordination fees unless expressly stated in writing.